PRESS RELEASE published on 05/20/2025 at 22:10, 1 year 5 months ago GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie GENFIT va recevoir un paiement d'étape de 26,5 millions d'euros suite à l'approbation d'Iqirvo® par Ipsen en Italie pour le traitement de la cholangite biliaire primitive Approbation GENFIT Paiement D'étape Ipsen Iqirvo®
PRESS RELEASE published on 05/20/2025 at 22:10, 1 year 5 months ago GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy GENFIT to receive a €26.5 million milestone payment for pricing approval of Ipsen's Iqirvo® in Italy. This unlocks a new phase for pipeline progress in liver diseases Approval GENFIT Milestone Payment Ipsen Iqirvo®
BRIEF published on 05/14/2025 at 22:15, 1 year 5 months ago GENFIT Releases 2025 Extra-Financial Performance Report for 2024 Sustainability ESG Biopharmaceutical Corporate Responsibility GENFIT
BRIEF published on 05/14/2025 at 22:15, 1 year 5 months ago GENFIT publie son rapport de performance extra-financière 2025 pour 2024 ESG Biopharmaceutique Durabilité Responsabilité D'entreprise GENFIT
PRESS RELEASE published on 05/14/2025 at 22:10, 1 year 5 months ago GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024) GENFIT publishes 2025 Extra-Financial Performance Report for fiscal year 2024. Focus on sustainability, ESG approach, social responsibility commitment, and liver disease research Sustainability GENFIT ESG Approach 2025 Extra-Financial Performance Report Liver Disease Research
BRIEF published on 05/07/2025 at 22:15, 1 year 5 months ago GENFIT prépare son Assemblée Générale Mixte de juin 2025 Assemblée Générale Biopharmaceutique Documentation GENFIT Vote En Ligne
BRIEF published on 05/07/2025 at 22:15, 1 year 5 months ago GENFIT prepares its Combined General Meeting in June 2025 Biopharmaceuticals General Assembly Documentation GENFIT Online Voting
PRESS RELEASE published on 05/07/2025 at 22:10, 1 year 5 months ago GENFIT : Assemblée Générale Mixte du 17 juin 2025 — modalités de mise à disposition des documents préparatoires GENFIT annonce l'Assemblée Générale Mixte du 17 juin 2025 et la mise à disposition des documents préparatoires. Retransmission en ligne et vote par Internet disponibles Assemblée Générale Biopharmaceutique Documents Préparatoires GENFIT Vote En Ligne
PRESS RELEASE published on 05/07/2025 at 22:10, 1 year 5 months ago GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents GENFIT announces Annual Combined General Meeting on June 17, 2025, providing shareholders with preparatory documents and online voting option. Company's focus on liver diseases and diverse R&D portfolio highlighted Shareholders Annual Meeting Liver Diseases GENFIT R&D Portfolio
BRIEF published on 05/05/2025 at 07:35, 1 year 5 months ago GENFIT to Showcase ACLF Research at EASL Congress 2025 Biopharmaceutical GENFIT EASL Congress ACLF Research Hepatology
Published on 10/30/2026 at 23:35, 1 day 21 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 21 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 1 hour ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 5 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 10 hours 15 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 15 hours 50 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 4 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 22 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 21 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 21 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie